Letters

Adjuvant trastuzumab for breast cancer: Editorial does not mention health economics of drug

BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.331.7526.1203 (Published 17 November 2005) Cite this as: BMJ 2005;331:1203
  1. E Hamish McLaren (handsmclaren@btinternet.com), retired consultant physician
  1. Badmany House, Beith, Ayrshire KA15 2JL

    EDITOR—Why does the BMJ, which promotes itself as a journal dedicated to evidence based medicine, publish an editorial that talks only of the hazard ratio of a treatment without any reference to the absolute reduction in recurrence observed? …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe